advertisement

Topcon

Molecular Neurodegeneration 11

Showing records 1 to 11 | Display all abstracts in Molecular Neurodegeneration

94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Risner ML
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Belforte N
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Pasini S
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Agostinone J; Alarcon-Martinez L
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
McGrady NR
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Villafranca-Baughman D
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
D'Alessandro KB
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Dotigny F
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Yao V; Cooper ML
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Cueva Vargas JL; Di Polo A
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Calkins DJ
Molecular Neurodegeneration 2021; 16: 36

Issue 22-2

Change Issue


advertisement

Oculus